ERTUGLIFLOZIN MITIGATES LIVER DAMAGE DURING SEPSIS: EVIDENCE FROM A MURINE MODEL
DOI:
https://doi.org/10.22159/ijap.2026v18i1.56581Keywords:
Ertugliflozin, Extracellular regulated kinases 1/2, Cecal ligation and puncture, Liver damage, SepsisAbstract
Objective: This study sought to examine the liver-protective effects of ertugliflozin in male mice subjected to CLP-induced sepsis.
Methods: Overall, 24 male albino Swiss mice, aged eight to twelve weeks and weighing 25–35 g, were segregated into four separate groups (n=6 each): the Sham, CLP, CLP+DMSO, and CLP+ertugliflozin groups. In the sham group, the mice were anaesthetized and subjected to laparotomy without cecal ligation and puncture (CLP), whereas in the sepsis group, the mice underwent CLP. The CLP+DMSO group received DMSO (the vehicle for ertugliflozin) through intraperitoneal injection one hour before CLP. In the CLP+ertugliflozin group, 20 mg/kg was administered via the intraperitoneal method one hour before CLP. Biochemical indicators (GPT, GOT, IL-6, TNFα, MDA, GSH, Bax, pERK1/2, and caspase-3) and histological changes were assessed.
Results: ELISA was used to investigate the levels of the study parameters in hepatic tissues. Compared with those in the sham group, the levels of TNFα, IL6, Bax, caspase3, MDA and phospho-ERK1/2 were significantly elevated in the mice subjected to sepsis via caecal ligation and puncture (CLP), whereas the GSH level was significantly decreased. In contrast, treatment of septic mice with ertugliflozin significantly reduced these parameters in comparison with those of the sepsis group. Furthermore, histopathological examination revealed that the occurrence of sepsis via CLP resulted in significant liver damage compared with that in the sham group. Conversely, the treatment of mice subjected to CLP with ertugliflozin significantly mitigated liver injury.
Conclusion: Ertugliflozin, which inhibits SGLT2, has significant hepatoprotective effects on CLP-induced sepsis, mainly via its antioxidant, anti-inflammatory, and antiapoptotic effects.
References
1. Fleischmann C, Scherag A, Adhikari NK, Hartog CS, Tsaganos T, Schlattmann P. Assessment of global incidence and mortality of hospital-treated sepsis: current estimates and limitations. Am J Respir Crit Care Med. 2016;193(3):259-72. doi: 10.1164/rccm.201504-0781OC, PMID 26414292.
2. Seymour CW, Liu VX, Iwashyna TJ, Brunkhorst FM, Rea TD, Scherag A. Assessment of clinical criteria for sepsis: for the third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):762-74. doi: 10.1001/jama.2016.0288, PMID 26903335.
3. Saini K, Bolia R, Bhat NK. Incidence predictors and outcome of sepsis-associated liver injury in children: a prospective observational study. Eur J Pediatr. 2022;181(4):1699-707. doi: 10.1007/s00431-022-04374-2, PMID 35020050.
4. Woznica EA, Inglot M, Woznica RK, Lysenko L. Liver dysfunction in sepsis. Adv Clin Exp Med. 2018;27(4):547-51. doi: 10.17219/acem/68363, PMID 29558045.
5. Yan J, Li S, Li S. The role of the liver in sepsis. Int Rev Immunol. 2014;33(6):498-510. doi: 10.3109/08830185.2014.889129, PMID 24611785.
6. Rubio I, Osuchowski MF, Shankar Hari M, Skirecki T, Winkler MS, Lachmann G. Current gaps in sepsis immunology: new opportunities for translational research. Lancet Infect Dis. 2019;19(12):e422-36. doi: 10.1016/S1473-3099(19)30567-5, PMID 31630991.
7. Traeger T, Mikulcak M, Eipel C, Abshagen K, Diedrich S, Heidecke CD. Kupffer cell depletion reduces hepatic inflammation and apoptosis but decreases survival in abdominal sepsis. Eur J Gastroenterol Hepatol. 2010;22(9):1039-49. doi: 10.1097/MEG.0b013e32833847db, PMID 20300005.
8. Waseem N, Chen PH. Hypoxic hepatitis: a review and clinical update. J Clin Transl Hepatol. 2016;4(3):263-8. doi: 10.14218/JCTH.2016.00022, PMID 27777895.
9. La Mura V, Pasarin M, Meireles CZ, Miquel R, Rodriguez Vilarrupla A, Hide D. Effects of simvastatin administration on rodents with lipopolysaccharide-induced liver microvascular dysfunction. Hepatology. 2013;57(3):1172-81. doi: 10.1002/hep.26127, PMID 23184571.
10. Strnad P, Tacke F, Koch A, Trautwein C. Liver guardian modifier and target of sepsis. Nat Rev Gastroenterol Hepatol. 2017;14(1):55-66. doi: 10.1038/nrgastro.2016.168, PMID 27924081.
11. Jia Y, Li Z, Feng Y, Cui R, Dong Y, Zhang X. Methane-rich saline ameliorates sepsis induced acute kidney injury through anti-inflammation, antioxidative and antiapoptosis effects by regulating endoplasmic reticulum stress. Oxid Med Cell Longev. 2018;2018:4756846. doi: 10.1155/2018/4756846, PMID 30581532.
12. Qassam H, Janabi AM, Gaen KK, Hadi NR. Dimethyl fumarate attenuates liver injury in a mouse model of cecal ligation and puncture by modulating inflammatory angiogenic and pyroptotic pathways. BMC Pharmacol Toxicol. 2025;26(1):134. doi: 10.1186/s40360-025-00968-2, PMID 40676712.
13. Jeong SJ, Han SH, Kim CO, Choi JY, Kim JM. Anti-vascular endothelial growth factor antibody attenuates inflammation and decreases mortality in an experimental model of severe sepsis. Crit Care. 2013;17(3):R97. doi: 10.1186/cc12742, PMID 23710641.
14. Ibrahim YF, Fadl RR, Ibrahim S, Gayyed MF, Bayoumi A, Refaie M. Protective effect of febuxostat in sepsis-induced liver and kidney injuries after cecal ligation and puncture with the impact of xanthine oxidase interleukin 1β, and c-Jun N-terminal kinases. Hum Exp Toxicol. 2020;39(7):906-19. doi: 10.1177/0960327120905957, PMID 32054342.
15. Siempos II, Lam HC, Ding Y, Choi ME, Choi AM, Ryter SW. Cecal ligation and puncture-induced sepsis as a model to study autophagy in mice. J Vis Exp. 2014;(84):e51066. doi: 10.3791/51066, PMID 24561344.
16. Abd Uljaleel A, Hassan E. Protective effect of ertugliflozin against acute lung injury caused by endotoxemia model in mice. Iran J War Public Health. 2023;15(1):67-75. doi: 10.58209/ijwph.15.1.67.
17. Alaasam ER, Janabi AM, Al Buthabhak KM, Almudhafar RH, Hadi NR, Alexiou A. Nephroprotective role of resveratrol in renal ischemia reperfusion injury: a preclinical study in sprague-dawley rats. BMC Pharmacol Toxicol. 2024;25(1):82. doi: 10.1186/s40360-024-00809-8, PMID 39468702.
18. Alkhafaji GA, Janabi AM. GIP/GLP-1 dual agonist tirzepatide ameliorates renal ischemia/reperfusion damage in rats. Int J App Pharm. 2025;17(2):165-73. doi: 10.22159/ijap.2025v17i2.53156.
19. Q Jallawee H, Janabi AM. Trandolapril improves renal ischemia reperfusion injury in adult male rats via activation of the autophagy pathway and inhibition of inflammation oxidative stress and apoptosis. J Biosci Appl Res. 2024;10(6):114-27. doi: 10.21608/jbaar.2024.315239.1077.
20. Alkhafaji GA, Janabi AM. Protective effects of bexagliflozin on renal function in a rat model of ischemia-reperfusion injury; an experimental animal study. J Nephropharmacol. 2025;14(2):e12760. doi: 10.34172/npj.2025.12760.
21. Tiba AT, Qassam H, Hadi NR. Semaglutide in renal ischemia-reperfusion injury in mice. J Med Life. 2023;16(2):317-24. doi: 10.25122/jml-2022-0291, PMID 36937464.
22. Chowdhury AB, Mehta KJ. Liver biopsy for assessment of chronic liver diseases: a synopsis. Clin Exp Med. 2023;23(2):273-85. doi: 10.1007/s10238-022-00799-z, PMID 35192111.
23. Esmon CT, Fukudome K, Mather T, Bode W, Regan LM, Stearns Kurosawa DJ. Inflammation sepsis and coagulation. Haematologica. 1999;84(3):254-9. PMID 10189392.
24. Jacobi J. Pathophysiology of sepsis. Am J Health Syst Pharm. 2002;59(Suppl 1):S3-8. doi: 10.1093/ajhp/59.suppl_1.S3, PMID 11885412.
25. Kobashi H, Toshimori J, Yamamoto K. Sepsis-associated liver injury: incidence, classification and the clinical significance. Hepatol Res. 2013;43(3):255-66. doi: 10.1111/j.1872-034X.2012.01069.x, PMID 22971102.
26. Jeschke MG, Rensing H, Klein D, Schubert T, Mautes AE, Bolder U. Insulin prevents liver damage and preserves liver function in lipopolysaccharide-induced endotoxemic rats. J Hepatol. 2005;42(6):870-9. doi: 10.1016/j.jhep.2004.12.036, PMID 15885358.
27. Hotchkiss RS, Tinsley KW, Swanson PE, Chang KC, Cobb JP, Buchman TG. Prevention of lymphocyte cell death in sepsis improves survival in mice. Proc Natl Acad Sci USA. 1999;96(25):14541-6. doi: 10.1073/pnas.96.25.14541, PMID 10588741.
28. Pettila V, Hynninen M, Takkunen O, Kuusela P, Valtonen M. Predictive value of procalcitonin and interleukin 6 in critically ill patients with suspected sepsis. Intensive Care Med. 2002;28(9):1220-5. doi: 10.1007/s00134-002-1416-1, PMID 12209268.
29. Kareem RT, Abass MK. A potential anti-inflammatory effect of ertugliflozin in animal model. South Asian Res J Pharm Sci. 2024;6(3):84-8. doi: 10.36346/sarjps.2024.v06i03.006.
30. Alaasam ER, Janabi AM. Erythropoietin protects against renal ischemia/reperfusion injury in rats via inhibition of oxidative stress inflammation and apoptosis. J Contemp Med Sci. 2023;9(4):233-8. doi: 10.22317/jcms.v9i4.1405.
31. Alsaaty EH, Janabi AM. Moexipril improves renal ischemia/reperfusion injury in adult male rats. J Contemp Med Sci. 2024;10(1):25-30. doi: 10.22317/jcms.v10i1.1477.
32. Llorens Cebria C, Molina Van Den Bosch M, Vergara A, Jacobs Cacha C, Soler MJ. Antioxidant roles of SGLT2 inhibitors in the kidney. Biomolecules. 2022;12(1):143. doi: 10.3390/biom12010143, PMID 35053290.
33. Gao X, Yan X, Yin Y, Lin X, Zhang Q, Xia Y. Therapeutic targeting of apoptosis inhibitor of macrophage/CD5L in sepsis. Am J Respir Cell Mol Biol. 2019;60(3):323-34. doi: 10.1165/rcmb.2018-0272OC, PMID 30326743.
34. Yoon JH, Gores GJ. Death receptor-mediated apoptosis and the liver. J Hepatol. 2002;37(3):400-10. doi: 10.1016/S0168-8278(02)00209-X, PMID 12175638.
35. Mohammad AR, Shnaien AA, Alabsawy SK, Hassan ES. Protective effect of ipragliflozin on acute brain injury induced by endotoxemia in mice. Iran J War Public Health. 2023;15(3):225-31. doi: 10.58209/ijwph.15.3.225.
36. Park GB, Choi Y, Kim YS, Lee HK, Kim D, Hur DY. ROS-mediated JNK/p38-MAPK activation regulates Bax translocation in sorafenib-induced apoptosis of EBV-transformed B cells. Int J Oncol. 2014;44(3):977-85. doi: 10.3892/ijo.2014.2252, PMID 24402682.
37. Haddad JJ. The role of Bax/Bcl-2 and pro-caspase peptides in hypoxia/reperfusion-dependent regulation of MAPK(ERK): discordant proteomic effect of MAPK(p38). Protein Pept Lett. 2007;14(4):361-71. doi: 10.2174/092986607780363925, PMID 17504094.
38. Li S, Takahara T, Fujino M, Fukuhara Y, Sugiyama T, Li XK. Astaxanthin prevents ischemia-reperfusion injury of the steatotic liver in mice. PLOS One. 2017;12(11):e0187810. doi: 10.1371/journal.pone.0187810, PMID 29121675.
39. Hong JM, Kim SJ, Lee SM. Role of necroptosis in autophagy signaling during hepatic ischemia and reperfusion. Toxicol Appl Pharmacol. 2016;308:1-10. doi: 10.1016/j.taap.2016.08.010, PMID 27521978.
Published
How to Cite
Issue
Section
Copyright (c) 2026 SALSABEEL H. ALRUFAIE, ALI M. JANABI
This work is licensed under a Creative Commons Attribution 4.0 International License.